S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS/A in the pre-IPO sequence.
BEST SPAC II Acquisition Corp. is a blank check company seeking to merge with a consumer goods sector business, targeting enterprises valued between $200M and $1B. The IPO offers 10 million units at $10 each, with redemption rights for public shareholders and private placement units for insiders. The company has not yet identified a target and faces a 18-month deadline to complete a business combination.
2026-03-11 · 0001213900-26-025801
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS filing.
BEST SPAC II Acquisition Corp. is a blank check company targeting a business combination in the consumer goods sector, with an expanded enterprise value range of $200M-$1B. The current S-1/A filing increases the public offering size to 10M units ($100M) compared to the previous DRS filing's 5.5M units ($55M). The deadline for completing a business combination is extended to 18 months, with potential extensions requiring sponsor-funded trust account deposits. The filing includes detailed terms for private placement units, founder share conversions, and redemption rights for public shareholders.
2026-01-21 · 0001213900-26-005882
DRS
filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
BEST SPAC II Acquisition Corp. is a blank check company seeking to merge with or acquire a consumer goods sector business, targeting enterprises valued between $100M and $600M. The company is offering 5.5 million units at $10.00 each, with a 12-month deadline to complete an initial business combination, extendable by up to 6 months. The sponsor has committed to funding extensions and holds significant equity, with potential conflicts of interest. Shareholders may redeem shares post-combination, and the company faces risks related to execution, dilution, and reliance on sponsor financing.
2025-01-10 · 0001213900-25-002630